drugset / Trial / NCT05229029

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

NCT05229029 ↗

Phase 2 Unknown 196 enrolled Peking University Cancer Hospital & Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of Chinese herbal compound in improving fatigue symptoms and quality of life in patients with chemotherapy.

Timeline

Start
2020-04-02
Primary completion
2023-09-01
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject TCM Formula Traditional medicine (herbal / TCM) — —